An investigation for investors in GlobeImmune Inc (NASDAQ:GBIM) shares over potential securities laws violations by GlobeImmune was announced and NASDAQ:GBIM stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 06/22/2015 -- An investigation on behalf of investors in NASDAQ:GBIM shares over potential securities laws violations by GlobeImmune and certain of its directors and officers was announced.
Investors who purchased shares of GlobeImmune Inc (NASDAQ:GBIM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of GlobeImmune Inc (NASDAQ:GBIM) concerning whether a series of statements by GlobeImmune regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On June 10, 2015, GlobeImmune Inc announced that, "it is evaluating strategic options for the company. In conjunction with this process, the Board has authorized eliminating the majority of positions in its workforce. . . Following our recent data announcement in our hepatitis B program, this workforce reduction is a necessary action to conserve working capital and provide maximum flexibility in determining the future direction of GlobeImmune." Shares of GlobeImmune Inc (NASDAQ:GBIM) declined to as low as $2.60 per share on June 10, 2015.
On June 18, 2015, NASDAQ:GBIM shares closed at $2.86 pershare.
Those who purchased shares of GlobeImmune Inc (NASDAQ:GBIM) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego